Drug intelligence / Profile preview

Locycare

Development stage: Phase 3
Lead developer: Mahidol University
Modality: Small Molecules
Administration: Topical

Overview

Locycare is a topical nail gel formulation containing *Artemisia abrotanum* (Southernwood) extract and glycerin, specifically developed to address nail surface abnormalities such as brittleness, roughness, and pitting. The mechanism of action involves the humectant properties of glycerin, which penetrates the nail plate to increase hydration and flexibility, and the potential antimicrobial and anti-inflammatory effects of *Artemisia abrotanum* extract, which support the restoration of the nail's healthy appearance. The product was evaluated in a pilot clinical study conducted by Mahidol University to assess its efficacy in improving nail surface quality in adults with stable nail conditions.

Brand names: LocycareLocycare XL
Other names: Artemisia abrotanum and glycerin nail gel

Beyond the preview

Go deeper on Locycare.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Locycare.

Explore the full profile